{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T12:32:49Z","timestamp":1772541169172,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["16\/136\/33"],"award-info":[{"award-number":["16\/136\/33"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","award":["3.2 - 1184811 - KEN - SKP"],"award-info":[{"award-number":["3.2 - 1184811 - KEN - SKP"]}],"id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["TMA 2015 SF1001"],"award-info":[{"award-number":["TMA 2015 SF1001"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DELTAS Africa Initiative","award":["DEL-15-003"],"award-info":[{"award-number":["DEL-15-003"]}]},{"name":"DELTAS Africa Initiative","award":["107754\/Z\/15\/Z-DELTAS"],"award-info":[{"award-number":["107754\/Z\/15\/Z-DELTAS"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Asymptomatic carriage of malaria parasites is common in high transmission intensity areas and confounds clinical case definitions for research studies. This is important for investigations that aim to identify immune correlates of protection from clinical malaria. The proportion of fevers attributable to malaria parasites is widely used to define different thresholds of parasite density associated with febrile episodes. The varying intensity of malaria transmission was investigated to check whether it had a significant impact on the parasite density thresholds. The same dataset was used to explore an alternative statistical approach, using the probability of developing fevers as a choice over threshold cut-offs. The former has been reported to increase predictive power.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data from children monitored longitudinally between 2005 and 2017 from Junju and Chonyi in Kilifi, Kenya were used. Performance comparison of Bayesian-latent class and logistic power models in estimating malaria attributable fractions and probabilities of having fever given a parasite density with changing malaria transmission intensity was done using Junju cohort. Zero-inflated beta regressions were used to assess the impact of using probabilities to evaluate anti-merozoite antibodies as correlates of protection, compared with multilevel binary regression using data from Chonyi and Junju.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Malaria transmission intensity declined from over 49% to 5% between 2006 and 2017, respectively. During this period, malaria attributable fraction varied between 27\u201359% using logistic regression compared to 10\u201336% with the Bayesian latent class approach. Both models estimated similar patterns of fevers attributable to malaria with changing transmission intensities. The Bayesian latent class model performed well in estimating the probabilities of having fever, while the latter was efficient in determining the parasite density threshold. However, compared to the logistic power model, the Bayesian algorithm yielded lower estimates for both attributable fractions and probabilities of fever. In modelling the association of merozoite antibodies and clinical malaria, both approaches resulted in comparable estimates, but the utilization of probabilities had a better statistical fit.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Malaria attributable fractions, varied with an overall decline in the malaria transmission intensity in this setting but did not significantly impact the outcomes of analyses aimed at identifying immune correlates of protection. These data confirm the statistical advantage of using probabilities over binary data.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12936-022-04346-9","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T22:02:44Z","timestamp":1668204164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Malaria attributable fractions with changing transmission intensity: Bayesian latent class vs logistic models"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7757-7516","authenticated-orcid":false,"given":"Kennedy","family":"Mwai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Nkumama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amos","family":"Thairu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Mburu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Odera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinter","family":"Kimathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Nyamako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Tuju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samson","family":"Kinyanjui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eustasius","family":"Musenge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faith","family":"Osier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"4346_CR1","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1002\/sim.4780132206","volume":"13","author":"T Smith","year":"1994","unstructured":"Smith T, Schellenberg JA, Hayes R. Attributable fraction estimates and case definitions for malaria in endemic. Stat Med. 1994;13:2345\u201358.","journal-title":"Stat Med"},{"key":"4346_CR2","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1086\/430006","volume":"191","author":"TW Mwangi","year":"2005","unstructured":"Mwangi TW, Ross A, Snow RW, Marsh K. Case definitions of clinical malaria under different transmission conditions in Kilifi district. Kenya J Infect Dis. 2005;191:1932\u20139.","journal-title":"Kenya J Infect Dis"},{"key":"4346_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/1467-9876.00129","volume":"47","author":"P Vounatsou","year":"1998","unstructured":"Vounatsou P, Smith T, Smith AFM. Bayesian analysis of two-component mixture distributions applied to estimating malaria attributable fractions. J R Stat Soc Ser C (Appl Stat). 1998;47:575\u201387.","journal-title":"J R Stat Soc Ser C (Appl Stat)"},{"key":"4346_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0001-706X(93)90068-M","volume":"54","author":"T Smith","year":"1993","unstructured":"Smith T, Charlwood JD, Kihonda J, Mwankusye S, Billingsley P, Meuwissen J, et al. Absence of seasonal variation in malaria parasitaemia in an area of intense seasonal transmission. Acta Trop. 1993;54:55\u201372.","journal-title":"Acta Trop"},{"key":"4346_CR5","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1080\/03610929708832007","volume":"26","author":"T Smith","year":"1997","unstructured":"Smith T, Vounatsou P. Logistic regression and latent class models for estimating positivities in diagnostic assays with poor resolution. Commun Stat Methods. 1997;26:1677\u2013700.","journal-title":"Commun Stat Methods"},{"key":"4346_CR6","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2307\/2532206","volume":"49","author":"S Greenland","year":"1993","unstructured":"Greenland S, Drescher K. Maximum likelihood estimation of the attributable fraction from logistic models. Biometrics. 1993;49:865\u201372.","journal-title":"Biometrics"},{"key":"4346_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015569","volume":"5","author":"A Olotu","year":"2010","unstructured":"Olotu A, Fegan G, Williams TN, Sasi P, Ogada E, Bauni E, et al. Defining clinical malaria: the specificity and incidence of endpoints from active and passive surveillance of children in rural Kenya. PLoS ONE. 2010;5: e15569.","journal-title":"PLoS ONE"},{"key":"4346_CR8","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1365-3156.2005.01418.x","volume":"10","author":"A Dicko","year":"2005","unstructured":"Dicko A, Mantel C, Kouriba B, Sagara I, Thera MA, Doumbia S, et al. Season, fever prevalence and pyrogenic threshold for malaria disease definition in an endemic area of Mali. Trop Med Int Health. 2005;10:550\u20136.","journal-title":"Trop Med Int Health"},{"key":"4346_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/1756-3305-4-241","volume":"4","author":"HE Atieli","year":"2011","unstructured":"Atieli HE, Zhou G, Lee MC, Kweka EJ, Afrane Y, Mwanzo I, et al. Topography as a modifier of breeding habitats and concurrent vulnerability to malaria risk in the western Kenya highlands. Parasit Vectors. 2011;4:241.","journal-title":"Parasit Vectors"},{"key":"4346_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032929","volume":"7","author":"A Olotu","year":"2012","unstructured":"Olotu A, Fegan G, Wambua J, Nyangweso G, Ogada E, Drakeley C, et al. Estimating individual exposure to malaria using local prevalence of malaria infection in the field. PLoS ONE. 2012;7: e32929.","journal-title":"PLoS ONE"},{"key":"4346_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002047","volume":"13","author":"P Mogeni","year":"2016","unstructured":"Mogeni P, Williams TN, Fegan G, Nyundo C, Bauni E, Mwai K, et al. Age, spatial, and temporal variations in hospital admissions with malaria in Kilifi County, Kenya: a 25-year longitudinal observational study. PLoS Med. 2016;13: e1002047.","journal-title":"PLoS Med"},{"key":"4346_CR12","doi-asserted-by":"publisher","first-page":"247ra102","DOI":"10.1126\/scitranslmed.3008705","volume":"6","author":"FH Osier","year":"2014","unstructured":"Osier FH, Mackinnon MJ, Crosnier C, Fegan G, Kamuyu G, Wanaguru M, et al. New antigens for a multicomponent blood-stage malaria vaccine. Sci Transl Med. 2014;6:247ra102-247ra102.","journal-title":"Sci Transl Med"},{"key":"4346_CR13","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.15186.1","author":"MK Muthui","year":"2019","unstructured":"Muthui MK, Mogeni P, Mwai K, Nyundo C, Macharia A, Williams TN, et al. Gametocyte carriage in an era of changing malaria epidemiology: a 19-year analysis of a malaria longitudinal cohort. Wellcome Open Res. 2019. https:\/\/doi.org\/10.12688\/wellcomeopenres.15186.1.","journal-title":"Wellcome Open Res"},{"key":"4346_CR14","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/S0140-6736(13)62566-0","volume":"383","author":"AM Noor","year":"2014","unstructured":"Noor AM, Kinyoki DK, Mundia CW, Kabaria CW, Mutua JW, Alegana VA, et al. The changing risk of Plasmodium falciparum malaria infection in Africa: 2000\u201310: a spatial and temporal analysis of transmission intensity. Lancet. 2014;383:1739\u201347.","journal-title":"Lancet"},{"key":"4346_CR15","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/S0140-6736(08)61655-4","volume":"372","author":"WP O\u2019Meara","year":"2008","unstructured":"O\u2019Meara WP, Bejon P, Mwangi TW, Okiro EA, Peshu N, Snow RW, et al. Effect of a fall in malaria transmission on morbidity and mortality in Kilifi. Kenya Lancet. 2008;372:1555\u201362.","journal-title":"Kenya Lancet"},{"key":"4346_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128792","volume":"10","author":"RW Snow","year":"2015","unstructured":"Snow RW, Kibuchi E, Karuri SW, Sang G, Gitonga CW, Mwandawiro C, et al. Changing malaria prevalence on the Kenyan coast since 1974: climate, drugs and vector control. PLoS ONE. 2015;10: e0128792.","journal-title":"PLoS ONE"},{"key":"4346_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0031182099005211","volume":"120","author":"P Vounatsou","year":"2000","unstructured":"Vounatsou P, Smith T, Kitua AY, Alonso PL, Tanner M. Apparent tolerance of Plasmodium falciparum in infants in a highly endemic area. Parasitology. 2000;120:1\u20139.","journal-title":"Parasitology"},{"key":"4346_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2202\/1557-4679.1201","volume":"6","author":"DS Small","year":"2010","unstructured":"Small DS, Cheng J, Ten Have TR. Evaluating the efficacy of a malaria vaccine. Int J Biostat. 2010;6:4.","journal-title":"Int J Biostat"},{"key":"4346_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1475-2875-6-53","volume":"6","author":"TA Smith","year":"2007","unstructured":"Smith TA. Measures of clinical malaria in field trials of interventions against Plasmodium falciparum. Malar J. 2007;6:53.","journal-title":"Malar J"},{"key":"4346_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12874-019-0667-2","volume":"19","author":"M Thoresen","year":"2019","unstructured":"Thoresen M. Spurious interaction as a result of categorization. BMC Med Res Methodol. 2019;19:28.","journal-title":"BMC Med Res Methodol"},{"key":"4346_CR21","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1002\/sim.6986","volume":"35","author":"GS Collins","year":"2016","unstructured":"Collins GS, Ogundimu EO, Cook JA, Le MY, Altman DG. Quantifying the impact of different approaches for handling continuous predictors on the performance of a prognostic model. Stat Med. 2016;35:4124\u201335.","journal-title":"Stat Med"},{"key":"4346_CR22","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","volume":"332","author":"DG Altman","year":"2006","unstructured":"Altman DG, Royston P. The cost of dichotomising continuous variables. BMJ. 2006;332:1080.","journal-title":"BMJ"},{"key":"4346_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-10-103","author":"KF Fr\u00f8slie","year":"2010","unstructured":"Fr\u00f8slie KF, R\u00f8islien J, Laake P, Henriksen T, Qvigstad E, Veier\u00f8d MB. Categorisation of continuous exposure variables revisited. A response to the hyperglycaemia and adverse pregnancy outcome (HAPO) study. BMC Med Res Methodol. 2010. https:\/\/doi.org\/10.1186\/1471-2288-10-103.","journal-title":"BMC Med Res Methodol"},{"key":"4346_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/00001648-199507000-00002","volume":"6","author":"CR Weinberg","year":"1995","unstructured":"Weinberg CR. How bad is categorization? Epidemiology. 1995;6:345\u20137.","journal-title":"Epidemiology"},{"key":"4346_CR25","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1128\/IAI.01358-08","volume":"77","author":"P Bejon","year":"2009","unstructured":"Bejon P, Warimwe G, Mackintosh CL, Mackinnon MJ, Kinyanjui SM, Musyoki JN, et al. Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure. Infect Immun. 2009;77:1917\u201323.","journal-title":"Infect Immun"},{"key":"4346_CR26","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1016\/j.vaccine.2013.06.042","volume":"31","author":"LM Murungi","year":"2013","unstructured":"Murungi LM, Kamuyu G, Lowe B, Bejon P, Theisen M, Kinyanjui SM, et al. A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria. Vaccine. 2013;31:3936\u201342.","journal-title":"Vaccine"},{"key":"4346_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.pt.2016.11.006","volume":"33","author":"IN Nkumama","year":"2017","unstructured":"Nkumama IN, O\u2019Meara WP, Osier FHA. Changes in malaria epidemiology in Africa and new challenges for elimination. Trends Parasitol. 2017;33:128\u201340.","journal-title":"Trends Parasitol"},{"issue":"5","key":"4346_CR28","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.vaccine.2004.05.031","volume":"23","author":"SD Polley","year":"2004","unstructured":"Polley SD, Mwangi T, Kocken CHM, Thomas AW, Dutta S, Lanar DE, et al. Human antibodies to recombinant protein constructs of Plasmodium falciparum apical membrane antigen 1 (AMA1) and their associations with protection from malaria. Vaccine. 2004;23(5):718\u201328.","journal-title":"Vaccine"},{"key":"4346_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-3024.2006.00808.x","volume":"28","author":"K Marsh","year":"2006","unstructured":"Marsh K, Kinyanjui S. Immune effector mechanisms in malaria. Parasite Immunol. 2006;28:51\u201360.","journal-title":"Parasite Immunol"},{"key":"4346_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0169-4758(94)90179-1","volume":"10","author":"JRMA Schellenberg","year":"1994","unstructured":"Schellenberg JRMA, Smith T, Alonso PL, Hayes RJ. What is clinical malaria? Finding case definitions for field research in highly endemic areas. Parasitol Today. 1994;10:439\u201342.","journal-title":"Parasitol Today"},{"key":"4346_CR31","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/S0140-6736(97)02038-2","volume":"349","author":"RW Snow","year":"1997","unstructured":"Snow RW, Omumbo JA, Lowe B, Molyneux CS, Obiero JO, Palmer A, et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet. 1997;349:1650\u20134.","journal-title":"Lancet"},{"key":"4346_CR32","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702\u20136.","journal-title":"Am J Epidemiol"},{"key":"4346_CR33","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/ije\/dys062","volume":"41","author":"JAG Scott","year":"2012","unstructured":"Scott JAG, Bauni E, Moisi JC, Ojal J, Gatakaa H, Nyundo C, et al. Profile: the Kilifi health and demographic surveillance system (KHDSS). Int J Epidemiol. 2012;41:650\u20137.","journal-title":"Int J Epidemiol"},{"key":"4346_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pctr.0010029","volume":"1","author":"P Bejon","year":"2006","unstructured":"Bejon P, Mwacharo J, Kai O, Mwangi T, Milligan P, Todryk S, et al. A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya. PLoS Clin Trial. 2006;1: e29.","journal-title":"PLoS Clin Trial"},{"key":"4346_CR35","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria.  2021. https:\/\/www.r-project.org\/. Accessed 25 Aug 2022."},{"key":"4346_CR36","unstructured":"Spiegelhalter D, Thomas A, Best N, Lunn D. OpenBUGS user manual. Version 3.2.3.  2007. https:\/\/www.mrc-bsu.cam.ac.uk\/wp-content\/uploads\/2021\/06\/OpenBUGS_Manual.pdf.  Accessed 25 Aug 2022."},{"key":"4346_CR37","unstructured":"Buis M. ZOIB: Stata module to fit a zero-one inflated beta distribution by maximum likelihood. Stat Softw Components. S457156, Boston College Department of Economics. 2012. https:\/\/ideas.repec.org\/c\/boc\/bocode\/s457156.html. Accessed 25 Aug 2022."},{"key":"4346_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.32614\/RJ-2015-019","volume":"7","author":"F Liu","year":"2015","unstructured":"Liu F, Kong Y. zoib: an R package for Bayesian inference for beta regression andzero\/one inflated beta regression. R J. 2015;7:34.","journal-title":"R J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04346-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-022-04346-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04346-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T22:07:10Z","timestamp":1668204430000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-022-04346-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4346"],"URL":"https:\/\/doi.org\/10.1186\/s12936-022-04346-9","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]},"assertion":[{"value":"12 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was given ethical approval by the University of Witwatersrand\u2019s Human Research Ethics Committee (HREC-Medical) (Clearance Certificate No. M190121) and KEMRI- Scientific and Ethics Review Unit (SERU) (Approval numbers KEMRI SSC No. 3139). Informed consent was collected from parents\/guardians before the beginning of recruitment. All experiments were carried out following relevant guidelines and regulations of SERU and HREC-Medical.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"326"}}